Haematological improvement as a beneficial effect during deferasirox treatment in transfusion-dependent patients with myelodysplastic syndrome

被引：6
|
作者：
Molica, Matteo [1 ]
Salaroli, Adriano [1 ]
Alimena, Giuliana [1 ]
Breccia, Massimo [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy
来源：
BLOOD TRANSFUSION | 2014年 / 12卷
关键词：
D O I：
10.2450/2013.0005-13
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S162 / S163
页数：2
相关论文
共 50 条
  • [21] Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion-dependent patients with myelodysplastic syndromes
    Piciocchi, Alfonso
    Sargentini, Valeria
    Cotugno, Francesca
    Bontempi, Katia
    Beltrami, Germana
    Di Tucci, Anna Angela
    Riva, Marta
    Quaresmini, Giulia
    Vallisa, Daniele
    Finelli, Carlo
    Borin, Lorenza
    Fazi, Paola
    Vignetti, Marco
    Angelucci, Emanuele
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (05) : 442 - 443
  • [22] Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)
    Angelucci, Emanuele
    Santini, Valeria
    Di Tucci, Anna Angela
    Quaresmini, Giulia
    Finelli, Carlo
    Volpe, Antonio
    Quarta, Giovanni
    Rivellini, Flavia
    Sanpaolo, Grazia
    Cilloni, Daniela
    Salvi, Flavia
    Caocci, Giovanni
    Molteni, Alfredo
    Vallisa, Daniele
    Voso, Maria Teresa
    Fenu, Susanna
    Borin, Lorenza
    Latte, Giancarlo
    Alimena, Giuliana
    Storti, Sergio
    Piciocchi, Alfonso
    Fazi, Paola
    Vignetti, Marco
    Tura, Sante
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (06) : 527 - 536
  • [23] DEFERASIROX EFFICACY IS INDIPENDENT BY IMPROVEMENT OF IRON OVERLOAD BIOCHEMICAL MARKERS IN TRANSFUSION DEPENDENT MYELODYSPLASTIC PATIENTS
    Volpe, M.
    Volpe, A.
    HAEMATOLOGICA, 2012, 97 : 708 - 708
  • [24] COMBINED CHELATION THERAPY WITH DEFERASIROX AND DEFEROXAMINE IN TRANSFUSION-DEPENDENT PATIENTS WITH THALASSEMIA
    Ladis, V.
    Delaporta, P.
    Kyriakopoulou, D.
    Kattamis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 703 - 703
  • [25] Transfusion-dependent low-risk myelodysplastic patients receiving deferasirox: Long-term follow-up
    Improta, Salvatore
    Villa, Maria Rosaria
    Volpe, Antonio
    Lombardi, Angela
    Stiuso, Paola
    Cantore, Nicola
    Mastrullo, Lucia
    ONCOLOGY LETTERS, 2013, 6 (06) : 1774 - 1778
  • [26] Efficacy and safety of deferasirox (Exjade®) in chelation-naive and previously chelated patients with transfusion-dependent myelodysplastic syndromes (MDS)
    Schmid, M.
    Guerci-Bresler, A.
    Della Porta, M.
    Taylor, K.
    Habr, D.
    Domokos, G.
    Roubert, B.
    Rose, C.
    Gattermann, N.
    LEUKEMIA RESEARCH, 2009, 33 : S141 - S142
  • [27] Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes
    Roy, Noemi B. A.
    Myerson, Saul
    Schuh, Anna H.
    Bignell, Patricia
    Patel, Roger
    Wainscoat, Jim S.
    McGowan, Simon
    Marchi, Emanuele
    Atoyebi, Wale
    Littlewood, Tim
    Chacko, Joseph
    Vyas, Paresh
    Killick, Sally B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (04) : 521 - 524
  • [28] Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes
    Jansen, AJG
    Essink-Bot, ML
    Beckers, EAM
    Hop, WCJ
    Schipperus, MR
    van Rhenen, DJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (02) : 270 - 274
  • [29] Remission of transfusion-dependent myelodysplastic syndrome in association with respiratory tract infection
    Murphy, PT
    Fay, M
    Quinn, J
    O'Donnell, JR
    ANNALS OF HEMATOLOGY, 2005, 84 (09) : 614 - 615
  • [30] LEVELS OF TRANSFUSION BURDEN AND ASSOCIATED COSTS FOR PATIENTS WITH TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES
    DeZern, A. E.
    Binder, G.
    Rizvi, S.
    Corvino, F. A.
    Arikian, S. R.
    Surinach, A.
    Lee, J.
    Smith, B. D.
    HAEMATOLOGICA, 2016, 101 : 245 - 245
12345